LUNG CANCER

INTRODUCTION
Lung cancer begins in the lungs and
common among people who smoke.
Moreover, it may occur due to the
hereditary toxins that are common in
specific families (Bade, 2020). The survival
rate for lung cancer is certainly low,
however there are a number of treatment
options to help maximize lifespan for Figure 1. Lung Cancer Global Prevalence in 2020 (WCRF, 2022)
infected individuals. The most common
treatment options include chemotherapy,
surgery, and even drug prescriptions. DETECTION AND PREVENTION

Early detection is important to enhance the treatment process of lung cancer.

LITERATURE ANALYSIS
According to the World Cancer Research
Fund International, Lung cancer is the
second most prevalent type of cancer in
the world. The data established in 2020
showcased that during that year 2.2
million cases of lung cancer were reported.
Moreover, the survival rate for lung cancer
is the lowest in all types of cancer which
stands at a low of 18% in the five year
period of cancer patients (Schabath, 2019).
Furthermore, on an annual basis, the
cancer deaths are at 1.7 million, data that
has high death rates among patients
experiencing lung cancer.
The continued development of the lung
cancer from the lungs to other organs
make it a complicated type of cancer to
control in specific stages. In this case, there
are public information regarding the
prevention and management of cancer.
The current rate of detection of lung cancer at the early stages is at 18% based on
the screening processes encountered. The early detection through screening is
highly reliable to determine whether there are cancer cells attached to the
primary host at this point being within the lungs (Barta, 2019). Early detection
helps with prevention of further development of the cells to other organs which
becomes hard to prevent adversities or control the cancer.
Detection can also be based on the problems that lung cancer causes to the host.
Persistent coughs that last more than two weeks and that causes blood in the
coughs is a major sign of lung cancer. The patients might also feel pain and aches
when breathing and sometimes breathlessness. The problems observed can be
used to diagnose whether a patient might be experiencing cancer and further
taken for screening to determine the type of cancer experienced and the location
of the cancer cells in the human body.
While it is hard to identify the sole cause of cancer, lung cancer is mainly caused
by tobacco, carcinogens, and radons (Howlader et al. 2020). In this case, people
are often advised to prevent excessive smoking of tobacco due to the adverse
health effects it has on their bodies. Eating healthy diet is also a preventive
measure to ensure the body is strong and capable of withstanding minor body
intruders. The use of the identified plan helps in preventing damage to the lung
and provision of sufficient nutrient to the body to fight diseases.

CONCLUSION

The analysis of Lung cancer projects on the importance of understanding the preventive measures of the condition. It is the second
most prevalent form of cancer, and has a very high death rate. The public health information is reliable in enhancing preventive
measures, as well as advocating for constant screening among individuals who engage in massive smoking experiences. Entirely, the
provided information stands out on how to observe Lung Cancer, determining the statistics of the same and preventing the
condition.
 REFERENCES

Bade, B. C., & Cruz, C. S. D. (2020). Lung cancer 2020: epidemiology, etiology, and prevention. Clinics in
chest medicine, 41(1), 1-24.

Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019). Global epidemiology of lung cancer. Annals of
global health, 85(1).

Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., ... & Feuer, E. J. (2020).
The effect of advances in lung-cancer treatment on population mortality. New England Journal of
Medicine, 383(7), 640-649.

Schabath, M. B., & Cote, M. L. (2019). Cancer progress and priorities: lung cancer. Cancer epidemiology,
biomarkers & prevention, 28(10), 1563-1579.

WCRF (2022). Lung Cancer Statistics. Global Prevalence.

Yang, D., Liu, Y., Bai, C., Wang, X., & Powell, C. A. (2020). Epidemiology of lung cancer and lung cancer
screening programs in China and the United States. Cancer letters, 468, 82-87.